Novel antagonists for proteinase-activated receptor 2: inhibition of cellular and vascular responses in vitro and in vivo.
about
Proteinase-activated receptor-2 mediated inhibition of TNFalpha-stimulated JNK activation - A novel paradigm for G(q/11) linked GPCRsProtease and protease-activated receptor-2 signaling in the pathogenesis of atopic dermatitisLanthanide labeling of a potent protease activated receptor-2 agonist for time-resolved fluorescence analysis.PAR2 Modulators Derived from GB88.Interdicting protease-activated receptor-2-driven inflammation with cell-penetrating pepducinsModulating human proteinase activated receptor 2 with a novel antagonist (GB88) and agonist (GB110).The novel PAR2 ligand C391 blocks multiple PAR2 signalling pathways in vitro and in vivo.Pharmacophore-based virtual screening, biological evaluation and binding mode analysis of a novel protease-activated receptor 2 antagonist.β-Arrestin-2 mediates the proinflammatory effects of proteinase-activated receptor-2 in the airway.Development of highly potent protease-activated receptor 2 agonists via synthetic lipid tethering.Teleocidin A2 inhibits human proteinase-activated receptor 2 signaling in tumor cells.Protease activated receptor 2 (PAR2) modulators: a patent review (2010-2015).Tryptase is involved in the development of early ventilator-induced pulmonary fibrosis in sepsis-induced lung injury.Dual effect of the novel peptide antagonist K-14585 on proteinase-activated receptor-2-mediated signalling.GPCR theme editorial.Protease activated receptor-2 (PAR2): possible target of phytochemicals.
P2860
Q24318701-3B0B130A-B9E9-419F-B8BE-5AF2F221AEF5Q24632061-142C598A-EA5C-4231-B9C7-09A71636C59BQ34300774-D2030717-1A68-4152-A2E6-D21DE2632656Q34547663-36808539-60EE-45B8-88FC-33B1DF9EEF2AQ35002854-61F02BA7-CA13-454E-A582-2B72F868EF86Q36024903-53B4B856-D977-4514-A9CB-C6FD99DC235AQ36036250-2F7C036D-C5B3-4088-B527-53433FF4F157Q36124531-C6CC5A60-422E-43B4-95CA-9AF36139E1D4Q36339904-3159EA9E-AA78-4F03-A1FB-3887BBABCB06Q36710897-39F73BDC-8128-4DCD-BE2F-6ED143C2F92CQ37591794-A696F10B-D0CF-4D3D-8FE4-490874F4FB12Q38758445-A93F55CF-2DA3-4BDA-B60B-8767A3B23443Q39437767-B86F87D4-E5C7-4FB3-BE96-2DF984641668Q39774017-8B419C2D-5CE6-4AB7-B036-1F01F62710E6Q42951309-D52CF810-3A87-4B3C-BDE0-F0E1C6757EF7Q53005041-D50FCAD6-FF93-4D5F-AA4E-41669A8052EE
P2860
Novel antagonists for proteinase-activated receptor 2: inhibition of cellular and vascular responses in vitro and in vivo.
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Novel antagonists for proteina ...... esponses in vitro and in vivo.
@ast
Novel antagonists for proteina ...... esponses in vitro and in vivo.
@en
type
label
Novel antagonists for proteina ...... esponses in vitro and in vivo.
@ast
Novel antagonists for proteina ...... esponses in vitro and in vivo.
@en
prefLabel
Novel antagonists for proteina ...... esponses in vitro and in vivo.
@ast
Novel antagonists for proteina ...... esponses in vitro and in vivo.
@en
P2093
P2860
P1476
Novel antagonists for proteina ...... esponses in vitro and in vivo.
@en
P2093
A Kawabata
H Ishiwata
J Tagashira
M R Cunningham
P2860
P304
P356
10.1111/J.1476-5381.2009.00342.X
P407
P577
2009-09-01T00:00:00Z